Chesterfield, Mo (KSDK) -- St. Luke's Sleep Medicine and Research Center is now enrolling participants in a clinical study to evaluate the safety and effectiveness of the Apnex Hypoglossal Nerve Stimulation (HGNS) System, an implantable device, to treat obstructive sleep apnea (OSA).
The center is among the first worldwide to begin enrollment for this new study of the investigational device, and it is the only study site in the bistate area.
"Continuous positive airway pressure (CPAP), which involves a pressurized mask over the nose, is considered the 'gold standard' for the treatment of sleep apnea, but many people have difficulty tolerating it," said Paula Schweitzer, PhD, St. Luke's Sleep Medicine and Research Center director of research. "This implantable device offers a new approach for those who have not had success with CPAP or other sleep apnea treatments."
People interested in learning if they qualify for the Apnex Clinical Study may call 888-975-3370 or visit stlukes-stl.com/sleep. Qualified participants will receive the medical device and care free of charge.